Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease

Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease

Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We assessed the relevancy of IL-17 and IL-23 serum levels as potential biomarkers towards severe IBD discrimination and disease-related c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laura A. Lucaciu, Maria Ilieș, Ștefan C. Vesa, Radu Seicean, Shahida Din, Cristina Adela Iuga, Andrada Seicean
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Crohn’s disease
ulcerative colitis
IBD severity
interleukin-17
interleukin-23
biomarker
Medicine
R
Acceso en línea:https://doaj.org/article/f1c8d307f70440e395d642eebdfde893
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f1c8d307f70440e395d642eebdfde893

Ejemplares similares